Philadelphia, PA, United States of America

Kelvin C Luk

USPTO Granted Patents = 3 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Kelvin C Luk in Monoclonal Antibodies

Introduction

Kelvin C Luk is a prominent inventor based in Philadelphia, PA, known for his significant contributions to the field of biomedical research. He has been awarded three patents, showcasing his innovative approach to addressing critical health issues.

Latest Patents

One of his latest patents involves monoclonal antibodies against alpha-synuclein fibrils. This patent provides monoclonal antibodies that specifically bind to α-Synuclein, with a preference for α-Synuclein fibrils over the α-Synuclein monomer. The invention also includes methods for treating α-Synucleopathic diseases by administering these antibodies to affected subjects. Additionally, it outlines techniques for detecting α-Synuclein fibrils using the antibodies developed in this research.

Career Highlights

Kelvin C Luk is affiliated with the University of Pennsylvania, where he conducts his research and development work. His innovative contributions have positioned him as a key figure in the study of neurodegenerative diseases.

Collaborations

He collaborates with notable researchers such as Virginia Man-Yee Lee and John Q Trojanowski, enhancing the impact of his work through shared expertise and knowledge.

Conclusion

Kelvin C Luk's work in developing monoclonal antibodies represents a significant advancement in the treatment and detection of α-Synucleopathic diseases. His innovative spirit and collaborative efforts continue to drive progress in biomedical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…